These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34132999)

  • 21. Combined assessment of frailty and nutritional status can be a prognostic indicator after percutaneous coronary intervention.
    Noike R; Amano H; Hirano S; Tsubono M; Kojima Y; Oka Y; Aikawa H; Matsumoto S; Yabe T; Ikeda T
    Heart Vessels; 2023 Mar; 38(3):332-339. PubMed ID: 36171443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction Between Frailty and Access Site in Older Adults Undergoing Transcatheter Aortic Valve Replacement.
    Drudi LM; Ades M; Asgar A; Perrault L; Lauck S; Webb JG; Rassi A; Lamy A; Noiseux N; Peterson MD; Labinaz M; Lefèvre T; Popma JJ; Kim DH; Martucci G; Piazza N; Afilalo J
    JACC Cardiovasc Interv; 2018 Nov; 11(21):2185-2192. PubMed ID: 30343019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcatheter Aortic Valve Implantation in Elderly Patients With Aortic Valve Stenosis: The Role of Frailty, Malnutrition, and Sarcopenia.
    Sá MP; Erten O; Ramlawi B
    J Am Heart Assoc; 2022 Oct; 11(19):e027705. PubMed ID: 36172936
    [No Abstract]   [Full Text] [Related]  

  • 24. Sex-Specific Determinants of Outcomes After Transcatheter Aortic Valve Replacement.
    Pighi M; Piazza N; Martucci G; Lachapelle K; Perrault LP; Asgar AW; Lauck S; Webb JG; Popma JJ; Kim DH; Lefèvre T; Labinaz M; Lamy A; Peterson MD; Arora RC; Noiseux N; Trnkus A; Afilalo J
    Circ Cardiovasc Qual Outcomes; 2019 Mar; 12(3):e005363. PubMed ID: 30879326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Restricted mean survival time of older adults with severe aortic stenosis referred for transcatheter aortic valve replacement.
    Rodighiero J; Piazza N; Martucci G; Spaziano M; Lachapelle K; de Varennes B; Ouimet MC; Afilalo J
    BMC Cardiovasc Disord; 2020 Jun; 20(1):299. PubMed ID: 32552887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frailty and Bleeding in Older Adults Undergoing TAVR or SAVR: Insights From the FRAILTY-AVR Study.
    Bendayan M; Messas N; Perrault LP; Asgar AW; Lauck S; Kim DH; Arora RC; Langlois Y; Piazza N; Martucci G; Lefèvre T; Noiseux N; Lamy A; Peterson MD; Labinaz M; Popma JJ; Webb JG; Afilalo J
    JACC Cardiovasc Interv; 2020 May; 13(9):1058-1068. PubMed ID: 32381184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of the clinical frailty scale on long-term outcomes after transcatheter aortic valve implantation.
    Miyawaki N; Ishizu K; Shirai S; Miyahara K; Yamamoto K; Suenaga T; Otani A; Nakano K; Fukushima T; Ko E; Tsuru Y; Nakamura M; Morofuji T; Morinaga T; Hayashi M; Isotani A; Ohno N; Kakumoto S; Ando K
    Am Heart J; 2024 Sep; 275():141-150. PubMed ID: 38876408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improvement of Risk Prediction After Transcatheter Aortic Valve Replacement by Combining Frailty With Conventional Risk Scores.
    Schoenenberger AW; Moser A; Bertschi D; Wenaweser P; Windecker S; Carrel T; Stuck AE; Stortecky S
    JACC Cardiovasc Interv; 2018 Feb; 11(4):395-403. PubMed ID: 29471953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive assessment using the revised Hasegawa's dementia scale to determine the mid-term outcomes following transcatheter aortic valve replacement.
    Saji M; Tobaru T; Higuchi R; Hagiya K; Takamisawa I; Shimizu J; Iguchi N; Takanashi S; Takayama M; Isobe M
    J Cardiol; 2019 Sep; 74(3):206-211. PubMed ID: 31015001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gait Speed Can Predict Advanced Clinical Outcomes in Patients Who Undergo Transcatheter Aortic Valve Replacement: Insights From a Japanese Multicenter Registry.
    Kano S; Yamamoto M; Shimura T; Kagase A; Tsuzuki M; Kodama A; Koyama Y; Kobayashi T; Shibata K; Tada N; Naganuma T; Araki M; Yamanaka F; Shirai S; Mizutani K; Tabata M; Ueno H; Takagi K; Higashimori A; Otsuka T; Watanabe Y; Hayashida K
    Circ Cardiovasc Interv; 2017 Sep; 10(9):. PubMed ID: 28916601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends in vascular complications and associated treatment strategies following transfemoral transcatheter aortic valve replacement.
    Ullery BW; Jin R; Kirker EB; Hayes G; Siwek L; Brevig J; Hodson RW; Spinelli KJ
    J Vasc Surg; 2020 Oct; 72(4):1313-1324.e5. PubMed ID: 32169358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of objective nutritional status after transcatheter aortic valve replacement.
    Honda Y; Yamawaki M; Shigemitsu S; Kenji M; Tokuda T; Tsutumi M; Mori S; Sakamoto Y; Kobayashi N; Araki M; Hirano K; Sakai T; Ito Y
    J Cardiol; 2019 May; 73(5):401-407. PubMed ID: 30598388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of Short and Mid-Term Mortality and Morbidity in Patients With Severe Aortic Stenosis (Intermediate/High Risk) Who Underwent Transcatheter Aortic Valve Replacement and Surgical Aortic Valve Replacement.
    Yesiltas MA; Haberal İ; Kuserli Y; Yildiz A; Koyuncu AO; Özsoy SD
    Heart Surg Forum; 2020 Apr; 23(2):E212-E220. PubMed ID: 32364917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Effect and Relationship of Frailty Indices on Survival After Transcatheter Aortic Valve Replacement.
    Kiani S; Stebbins A; Thourani VH; Forcillo J; Vemulapalli S; Kosinski AS; Babaliaros V; Cohen D; Kodali SK; Kirtane AJ; Hermiller JB; Stewart J; Lowenstern A; Mack MJ; Guyton RA; Devireddy C;
    JACC Cardiovasc Interv; 2020 Jan; 13(2):219-231. PubMed ID: 31973795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of objective nutritional indexes on 1-year mortality after transcatheter aortic valve implantation: a prospective observational cohort study.
    Kucukosmanoglu M; Kilic S; Urgun OD; Sahin S; Yildirim A; Sen O; Kurt İH
    Acta Cardiol; 2021 Jun; 76(4):402-409. PubMed ID: 32306835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel geriatric assessment frailty score predicts 2-year mortality after transcatheter aortic valve implantation.
    Skaar E; Eide LSP; Norekvål TM; Ranhoff AH; Nordrehaug JE; Forman DE; Schoenenberger AW; Hufthammer KO; Kuiper KK; Bleie Ø; Packer EJS; Langørgen J; Haaverstad R; Schaufel MA
    Eur Heart J Qual Care Clin Outcomes; 2019 Apr; 5(2):153-160. PubMed ID: 30256921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utility of an additive frailty tests index score for mortality risk assessment following transcatheter aortic valve replacement.
    Steinvil A; Buchanan KD; Kiramijyan S; Bond E; Rogers T; Koifman E; Shults C; Xu L; Torguson R; Okubagzi PG; Pichard AD; Satler LF; Ben-Dor I; Waksman R
    Am Heart J; 2018 Jun; 200():11-16. PubMed ID: 29898837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Additive prognostic value of carbohydrate antigen-125 over frailty in patients undergoing transcatheter aortic valve replacement.
    Romeo FJ; Seropian IM; Chiabrando JG; Raleigh JV; Smietniansky M; Cal M; Falconi M; Kotowicz V; Agatiello CR; Berrocal DH
    Catheter Cardiovasc Interv; 2021 Feb; 97(2):E263-E273. PubMed ID: 32597028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aortic valve replacement for aortic stenosis in patients with left ventricular dysfunction.
    Halkos ME; Chen EP; Sarin EL; Kilgo P; Thourani VH; Lattouf OM; Vega JD; Morris CD; Vassiliades T; Cooper WA; Guyton RA; Puskas JD
    Ann Thorac Surg; 2009 Sep; 88(3):746-51. PubMed ID: 19699891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Five-year follow-up after transcatheter aortic valve implantation for symptomatic aortic stenosis.
    Zahn R; Werner N; Gerckens U; Linke A; Sievert H; Kahlert P; Hambrecht R; Sack S; Abdel-Wahab M; Hoffmann E; Zeymer U; Schneider S;
    Heart; 2017 Dec; 103(24):1970-1976. PubMed ID: 28684438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.